Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has emerged as one of the most studied weight loss medications, with landmark trials showing average reductions of 10–22% of initial body weight. However, the question of how much weight *you* can lose depends on multiple individual factors—not just the medication itself. Understanding realistic expectations and the science behind semaglutide helps you make an informed decision about your weight loss journey.
Clinical Weight Loss Results from Semaglutide Trials
The STEP trials, the largest clinical studies of semaglutide for weight loss, tracked over 4,500 adults across 16 weeks of treatment escalation followed by 52 weeks of maintenance dosing. Participants receiving the highest doses experienced average weight loss of 15–22% of their starting body weight, compared to 2–3% in placebo groups. At lower maintenance doses, weight loss averaged 10–15%. These figures represent substantial reductions: a 250-pound person might lose 25–55 pounds over the 68-week trial period.
Importantly, weight loss plateaus around 20 weeks of consistent dosing, meaning most reduction occurs in the first 4–6 months. After that, semaglutide helps maintain your weight loss rather than produce continuous decline. This plateau is normal physiology and does not indicate the medication has stopped working. Continuing the same dose preserves your achieved weight loss long-term.
Individual Factors That Shape Your Personal Weight Loss
Your own results will vary based on genetics, starting weight, age, sex, metabolism, and how strictly you follow dietary guidelines. A person with 100 pounds to lose may lose more total pounds than someone with 30 pounds to lose, even if their percentage loss is similar. Age and metabolic rate also play roles: younger adults sometimes respond faster, while those with metabolic conditions may see slower initial loss. Your baseline insulin resistance and whether you have type 2 diabetes can influence how your body responds.
Lifestyle adherence matters significantly. Semaglutide reduces hunger and cravings, but it is not a substitute for healthy eating and movement. Users who combine the injection with a balanced, protein-rich diet and regular physical activity consistently achieve higher weight loss than those relying on medication alone. PlexusDx's personalized approach helps identify your individual response profile, allowing your healthcare provider to optimize your dose and protocol for maximum effectiveness.
How Semaglutide Works to Support Weight Loss
Semaglutide is a GLP-1 receptor agonist, a class of medication that mimics a natural hormone your intestines produce when you eat. Activating GLP-1 receptors in your brain reduces hunger signals, increases feelings of fullness, and slows stomach emptying—all of which make it easier to eat less without constant willpower. The medication also improves blood sugar control, which can reduce cravings for carbohydrates and sugary foods that often drive weight regain.
The injectable form, which PlexusDx compounds in licensed 503A pharmacies, delivers consistent weekly dosing that maintains stable medication levels in your bloodstream. This steady-state approach often leads to more predictable results than oral forms, which have lower absorption rates. Many patients report that hunger simply diminishes—not through deprivation, but through genuine neurological change in how their brain signals appetite.
Realistic Timelines and What to Expect Month by Month
Week 1–4: Initial dose titration begins. Most people notice reduced appetite and slightly less interest in food, though weight loss is minimal (1–3 pounds). Some experience mild nausea, which typically resolves within days. Weeks 5–12: Dose escalates, and weight loss accelerates. Many users report 4–8 pounds lost per month during this phase. Energy may dip slightly as your body adjusts. Weeks 13–20: Weight loss reaches peak velocity for most people. Monthly loss may reach 6–10 pounds, depending on adherence and baseline metabolism. Weeks 21+: Loss slows to 2–4 pounds monthly, then stabilizes. Your dose remains the same, but weight loss plateaus as your body reaches its new equilibrium.
Reaching your goal weight is not guaranteed—semaglutide is a tool that works best with consistent diet and exercise. However, clinical data shows that 50–70% of users achieve clinically meaningful weight loss (≥10% of body weight) within 6 months, compared to fewer than 5% of people using diet and exercise alone. PlexusDx provides ongoing support to monitor progress, adjust doses if needed, and help you maintain results long-term.
Genetics and Personalization: Why Your Results May Differ from Others
Not everyone responds identically to semaglutide. Recent genetic research has identified specific variants in the GLP1R, GIPR, MC4R, and FTO genes that influence how efficiently your body responds to GLP-1 therapy. Someone with favorable variants in the GLP1R gene may achieve 20% weight loss, while a person with less-responsive variants might achieve 12–15% loss on the same dose. Neither outcome is a failure—it reflects your unique biology.
PlexusDx offers the Precision Peptide Genetic Test, which maps 14 metabolic pathways and analyzes 150+ genetic insights related to peptide-hormone signaling and weight regulation. This $99 add-on test (available after your first month of treatment) reveals whether you carry genetic variants that predict stronger or more modest responses to semaglutide. Knowing your genetic profile helps your PlexusDx provider set realistic expectations, potentially choose between semaglutide and tirzepatide (which activates different pathways), or adjust your treatment protocol for optimal results.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will I lose weight immediately after my first semaglutide injection?
No, immediate weight loss is not typical. Week one focuses on your body tolerating the initial low dose. Most noticeable appetite suppression and meaningful weight loss begin in weeks 2–4 as your dose escalates. Monthly weight loss accelerates during weeks 5–12 and peaks around weeks 13–20.
What is the average weight loss on semaglutide based on clinical trials?
STEP clinical trials showed average weight loss of 10–22% of body weight over 68 weeks, depending on maintenance dose. This means a 250-pound person could expect to lose 25–55 pounds on average. Individual results vary based on genetics, lifestyle, and adherence.
How much does PlexusDx compounded semaglutide cost, and is it covered by insurance?
PlexusDx semaglutide injections start at $149 per month with no flat per-compound pricing increases—your dose may go up, but your price won't. The medication is not insurance-dependent; you pay out-of-pocket. HSA and FSA accounts are eligible, and PlexusDx serves all 50 states with no membership fees.
What if I stop taking semaglutide—will I regain the weight?
Weight regain is common after stopping semaglutide, though not guaranteed. Many users maintain 50–70% of their weight loss long-term if they sustain lifestyle changes. Others regain weight gradually over months. Continuing semaglutide at your maintenance dose is the most reliable way to preserve results.
Can the Precision Peptide Genetic Test tell me if semaglutide will work for me?
The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 150+ genetic insights across 14 metabolic pathways, including variants in GLP1R, GIPR, MC4R, and FTO that influence GLP-1 therapy response. Your results help your PlexusDx provider predict your likely response range and optimize your treatment protocol for maximum effectiveness.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Do You Lose Weight on Semaglutide?
Is Compounded Semaglutide as Effective as FDA-Approved Options?